Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vir Biotechnology Inc
(NQ:
VIR
)
10.15
+0.05 (+0.50%)
Streaming Delayed Price
Updated: 2:21 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
318,901
Open
10.16
Bid (Size)
10.14 (5)
Ask (Size)
10.15 (5)
Prev. Close
10.10
Today's Range
10.03 - 10.34
52wk Range
7.720 - 27.48
Shares Outstanding
133,976,538
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
March 19, 2024
These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.
Via
InvestorPlace
Assessing Vir Biotechnology: Insights From 5 Financial Analysts
March 15, 2024
Via
Benzinga
Performance
YTD
-3.43%
-3.43%
1 Month
-14.71%
-14.71%
3 Month
-0.68%
-0.68%
6 Month
+9.61%
+9.61%
1 Year
-55.05%
-55.05%
More News
Read More
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
March 13, 2024
Via
InvestorPlace
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
March 05, 2024
From
Vir Biotechnology, Inc.
Via
Business Wire
Recap: Vir Biotechnology Q4 Earnings
February 22, 2024
Via
Benzinga
Earnings Outlook For Vir Biotechnology
February 21, 2024
Via
Benzinga
JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know
January 29, 2024
Via
Benzinga
3 Highly Rated Biotech Stocks to Buy for 300% Gains
February 26, 2024
Via
InvestorPlace
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 23, 2024
Via
Benzinga
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
February 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
February 23, 2024
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
February 22, 2024
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
February 20, 2024
From
Vir Biotechnology, Inc.
Via
Business Wire
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
February 14, 2024
Via
InvestorPlace
Earnings Scheduled For February 22, 2024
February 22, 2024
Via
Benzinga
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
February 01, 2024
From
Vir Biotechnology, Inc.
Via
Business Wire
HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here's What You Need To Know
January 23, 2024
Via
Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
Via
Benzinga
Exposures
COVID-19
Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
December 13, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
December 06, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
November 30, 2023
Via
InvestorPlace
From laggards to leaders: Small caps on the rise
November 27, 2023
Via
MarketBeat
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
November 13, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
November 10, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
November 08, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.